News Articles 11 - 20 of 160

28
Jan
THE GUTS UK / DR FALK PHARMA 2020 AWARDS ARE OPEN FOR APPLICATIONS
News Type: BASL News

The Guts UK / Dr Falk awards recognise the achievements of those who bring new insight to gastroenterology and hepatology, and the collaboration that furthers patient care. These awards are an opportunity to achieve national recognition as well as the financial support for career progression.

Awards available:
A £1,000 prize for the best essay on gastroenterology or hepatology research personally undertaken by medical students who were on an intercalated BSc/MRes/MSc/MPH/MBPhD* course during the previous academic year (2018-19).

Four £1,500 prizes for medical students taking full-time science degrees (BSc/MRes/MSc/MPH/MBPhD*) focusing on gastrointestinal or liver-related disease in the current academic year (2019-20).

Two £2,500 awards for F1/F2 doctors to facilitate prospective research in an area relevant to gastroenterology or hepatology.

A £1,000 award for primary and secondary care gastrointestinal/liver nurses for initiatives that have improved patient care. This year we are also inviting colleagues to nominate nurses to this award.

A £1,000 award for dietitians working in gastroenterology or hepatology for initiatives that have improved patient care.

Up to £10,000 is available for UK-based gastroenterology / hepatology SpR trainees who would like to conduct an audit or quality improvement project in any area of gastroenterology, liver disease or nutrition.

Applications close at 17:00 on Monday 6th April 2020.

For further information and to apply: https://gutscharity.org.uk/research/grants-and-awards/ 

* PhD students should note that they may apply for the medical student prize only once during their three-year studentship and that they may apply for the essay prize when their PhD has been completed.

06
Jan
Alcohol Health Alliance UK - Commission on Alcohol Harm calls for evidence
News Type: BASL News

The Commission on Alcohol Harm is today launching a call for evidence as part of its inquiry into alcohol harm and the changes needed to reduce the harm caused by alcohol.

The Commission will hold three oral evidence sessions across the UK later this year, and has launched a call for written evidence, with submissions welcomed before the deadline of 12 noon on 17 February 2020.

The Commission is interested in receiving evidence from academic researchers, charities, healthcare professionals, professional bodies, commissioners and those affected by alcohol harm in their personal, professional or family life.

Professor Sir Ian Gilmore, Chair of the Alcohol Health Alliance UK, said: “The Commission on Alcohol Harm is an extremely important investigation into how all parts of our society are impacted by our drinking habits.

“We need to have voices representing the wide range of experiences of alcohol harm; including those on the front-line, researchers and those with first hand experience of alcohol harm. Together, we can build a solid case for change.”

Baroness Finlay of Llandaff, Chair of the Commission on Alcohol Harm, said: “Alcohol plays a huge part of the everyday lives of many people across the UK, and therefore it is important to examine its impact on our society more closely. We need to understand how our drinking habits affect our own health as well as the way alcohol can affect those around us.

“We welcome the input of those who face the effects of alcohol harm in their professional or personal lives in order to help us make meaningful recommendations on a vision for the future.”

To share your views, please submit written evidence to harms_commission@ahauk.org  by 17 February 2020.

Visit the AHA website for submission guidelines: http://ahauk.org/commission-on-alcohol-harm/  .

24
Dec
President's Blog December
News Type: BASL News

On the verge of Christmas holidays, the final report of the Lancet Commission has been published and it calls out ‘unacceptable failures’. Harmful effects on health resulting from lifestyle causes have been unrelenting and the frustration growing with the burden on health services.

About 80% of cirrhosis occurs in individuals with at least one of the risk factors- alcohol excess, type 2 diabetes or obesity. Nearly half of the patients with cirrhosis are diagnosed when they are admitted to an in-patient service with acute problems. The outcome of patients with cirrhosis diagnosed as in-patients are worse than those diagnosed as out-patients even when corrected for the stage of cirrhosis. So, it is logical to look to diagnose cirrhosis earlier, intervene to prevent the decompensating episode with an intention to reduce hospitalisation.

UK National Screening Committee (NSC) invites new screening topics annually. On behalf of BASL, I have proposed a screening programme to identify cirrhosis among high-risk group using non-invasive tools that are now widely accessible, (link to Scarred Liver PDF -  Download UK NSC Annual Call Template Submission Form 2019 Scarred Liver BASL.pdf). Such a proposition is bound to be provocative, but, I hope that it generates serious debate.

Guruprasad Aithal
President, BASL

03
Dec
BASL Committee Communications and Website Lead Post - Nominations Close 13th December 2019
News Type: BASL News

The tenure of the current Communications and Website Lead will come to an end in January 2020 and as such, BASL are now seeking expressions of interest for this post.

The Communications and Website Lead is elected by the membership to serve for a period of up to three years and may be re-elected once. 

In addition to his/her role on the Governing Board, the post holder is responsible for working with the BASL Secretariat on any website upgrades, to increase BASL’s presence on social media and to work with the committee on developing the BASL member’s portal. A working knowledge of Twitter is desirable.

The post holder will be registered with Companies House in the UK as a Director of BASL and registered with the Charities Commission as a Trustee.

Nomination Process
Please send your nominations, clearly stating the position that your nomination is for, to the BASL Secretariat at judy@basl.org.uk by the deadline of 17:00 on Friday 13th December 2019.

Candidates wishing to be considered for this post require one BASL member to propose them and a second BASL member to confirm their suitability for the role in writing.

If more than one candidate is nominated, the Secretariat will arrange for an election of all members. He/she will be elected by simple majority of those members voting. A personal statement, containing no more than approx. 300 words, will be required from the candidate should an election need to take place.

The newly elected post will be announced in the January 2020 newsletter to members.

If you need any more information, please do not hesitate to contact judy@basl.org.uk .

03
Dec
BASL BVHG Secretary Post - Nominations Close 13th December 2019
News Type: BASL News

The tenure of the current Secretary will come to an end in January 2020 and as such the British Viral Hepatitis Group (BVHG) are now seeking expressions of interest for this post.

The British Viral Hepatitis Group aims to improve the management and study of patients with chronic viral liver disease, bringing together UK hepatologists, gastroenterologists, infectious disease physicians, virologists and interested epidemiologists.

The BVHG Secretary is elected by the BASL / BVHG membership to serve for a period of up to three
year’s and may be re-elected once. The Secretary is responsible for running the administrative tasks pertaining to his/her function and will work closely with the BASL Secretariat, which is appointed by the BASL Governing Board.

The main roles of the post are to support the BVHG Chair in the organisation of educational events and to help arrange the BASL / BVHG Hepatology and Viral School.

The BVHG is commissioned by the BASL Governing Board to:

• a) promote research and the exchange of scientific information concerning viral hepatitis;
• b) foster multicentre scientific studies pertaining to viral hepatitis within the UK;
• c) promote education of physicians, surgeons, clinical nurse specialists and scientists
• with regard to viral hepatitides and their management;
• d) Promote interaction between clinical disciplines to promote good care of patients and foster research and clinical trials.

Nomination Process
Please send your nominations, clearly stating the position that your nomination is for, to the BASL Secretariat at judy@basl.org.uk  by the deadline of 17:00 on Friday 13th December 2019. 

Candidates wishing to be considered for election will require one BASL member to propose them and a second BASL member to confirm their suitability for the role in writing.

If more than one candidate is nominated, the Secretariat will arrange for an election of all members. He/she will be elected by simple majority of those members voting. A personal statement, containing no more than approx. 300 words, will be required from the candidate should an election need to take place.

The newly elected post will be announced in the January 2020 newsletter to members.

If you require any further information about this role please contact the current post holder Dr Will Gelson at william.gelson@addenbrookes.nhs.uk  .

25
Oct
Annual call for topics open - UK NSC - closes midnight 4th December 2019
News Type: BASL News

The UK NSC has opened the annual call for new screening topics. It provides every individual, group or organisation with the opportunity to submit a proposal for a new screening programme. This window of opportunity closes at midnight on 4th December 2019.

If you wish to propose a new screening topic that is not already on the UK NSC list, the guidance, submission form and an example proposal are all available at the end of this link: https://www.gov.uk/government/publications/uk-nsc-evidence-review-process/appendix-d-how-to-submit-a-proposal-to-the-uk-nsc .

Please ensure you read through the guidance and use the template submission form which will guide you through all the requirements of a proposal.

For more information about the annual call please read our blog:
https://phescreening.blog.gov.uk/2019/09/05/annualcall2019/ 

Evidence Team
UK National Screening Committee
www.screening.nhs.uk 


24
Oct
Vacancy - Clinical lecturer in Gastroenterology/Hepatology - Birmingham - closing date 12 November
News Type: BASL News

Clinical lecturer in Gastroenterology/Hepatology - Institute of Immunology and Immunotherapy

College of Medical and Dental Sciences, University of Birmingham

  • Full Time for 5 Years, or until CCT plus 6 months (whichever is sooner)
  • Starting salary is normally in the range £31,931 to £59,401 a year
  • Closing date: 12 November 2019 Reference: 82161

The post is an HEFCE funded Clinical Lectureship at the University of Birmingham, in Gastroenterology/Hepatology. This post is available for 5 years or until CCT plus 6 months (whichever is sooner). It is, therefore, anticipated that the training programme will attract applicants who have already completed part of their higher specialist training in general medicine or gastroenterology.

The post-holders have responsibilities, which include the care of inpatients and outpatients with general medical and gastrointestinal or liver problems and which from time to time include teaching of introductory course students, final year students and postgraduate students and co-ordination of undergraduate medical examinations at the training hospital.

The appointee will be encouraged and supported to develop a programme of discovery and/or translational research in line with current areas of interest in the unit. The department has an international reputation in the following research areas including immunology, stromal cell and stem cell biology focusing on regeneration in inflammatory bowel and liver disease, and hepatocellular carcinoma. Another major area of interest is non-alcoholic fatty liver disease with strength in pre-clinical and clinical phases. The successful candidate would work closely within the £12M NIHR Biomedical Research Centre hosted in Birmingham which supports world-leading translational research.

The successful candidate will be appointed to the academic gastroenterology and hepatology training scheme.

Clinical placement will be divided between the Gastroenterology and Liver Unit at the Queen Elizabeth Hospital Birmingham. During the Gastroenterology placement there will be exposure to general medicine and acute medical takes. During the placement on the Liver Unit the candidate will participate in ward work, clinics as well as the on call rota. Clinical contribution will be on a 0.5 WTE basis.

Academic placement will be in the Centre for Liver and Gastrointestinal Research (CLGR) and the lecturer will benefit from the close collaboration between clinicians and scientists in the CLGR. Training will be overseen by Professor Newsome (Director of Centre) and Dr Shetty (Academic Training Lead for Gastroenterology/Hepatology). The Lecturer will be expected to develop a novel research programme under their supervision in line with those of the Centre, with a view to applying for clinician scientist/intermediate fellowship funding. The successful candidate would work closely within the £12M NIHR Biomedical Research Centre hosted in Birmingham and world leading experts and state of the art facilities in the Institute of Immunology and Immunotherapy.

PERSON SPEC
• A higher degree (MD/PhD) is desirable
• Ability to analyse information and communicate effectively
• Ability to access and organise resources successfully.

To download the details of this position and submit an electronic application online please visit the University of Birmingham website here > https://bit.ly/2pK8mm6

For informal queries please contact Prof P Newsome p.n.newsome@bham.ac.uk .

Alternatively information can be obtained from www.hr.bham.ac.uk or by visiting https://www.birmingham.ac.uk/staff/index.aspx .

 

23
Oct
New report on alcohol duty: cuts linked to 2,000 additional deaths
News Type: BASL News

new report from the Sheffield Alcohol Research Group, commissioned by the Institute of Alcohol Studies, finds that almost 2,000 people in England, and 250 in Scotland, have died as a result of recent government cuts to alcohol duty.

Tax on alcohol has been reduced in real-terms in five of the last six Budgets, and, as a consequence, there are estimated to have been:
- over 100,000 additional crimes,
- 500,000 additional days of work lost, and
- over 61,000 additional hospital admissions.

This comes at a cost to the NHS of £341 million. The report also finds that reintroducing the duty escalator, which ensured that tax rates rose by 2% above inflation each year, could reverse these trends. A duty escalator in place until 2032 is estimated to save over 4,700 lives. The Independent has the story.

These findings come at a crucial time for the AHA duty campaign and to support the AHA campaign. BASL has sent a letter to the Chancellor, see below, highlighting the need to increase alcohol duty by 2% in the upcoming Budget.  

Download Letter to Chancellor-Duty Campaign October 2019.pdf

Officials at the Treasury have told the AHA that they noticed the increase in letters asking for alcohol tax increases, both from organisations and MPs, so the campaign is having a real impact. 

26
Sep
Minimum price ‘cuts drinking by half a pint a week’
News Type: BASL News

‘Another string of evidence supports the effectiveness of introducing minimum price based on the strength of alcoholic drinks’.

The introduction of minimum pricing for alcohol in Scotland appears to have cut drinking, a study suggests.
View the article on the BBC News website here > https://www.bbc.co.uk/news/health-49831575 .

19
Sep
More than a quarter of people who die from liver disease in hospital have no previous admission in the year before their death
News Type: BASL News

Press Release -  British Liver Trust

More than a quarter of people who die from liver disease in hospital have no previous admission in the year before their death

New data released today at the largest conference for liver clinicians reveals that around 5,200 people die from liver disease in hospital in England each year. Of these, 30% of those have not had an admission in the year before death. On admission to hospital time is of the essence in saving these seriously ill patients. 1 in 4 of those who die do not survive more than 3 days and 43% do not survive a week.

These are people with advanced liver disease and many of their lives could have been saved if they had been diagnosed earlier in primary or secondary care and had been given advice on risk factors like alcohol and management of their liver disease.

The analysis is being presented at the British Association for the Study of the Liver conference in Glasgow. The data also reveals that these deaths occur in relatively young people. 60% of these patients are under 64 years of age and that one in five are under the age of 50.

Liver disease has increased by 400% since 1970 and it’s the biggest cause of death in those aged between 35-49 years old in the UK (https://britishlivertrust.org.uk/about-us/media-centre/statistics/ ).

This new data highlights the urgent need for improvements in early detection of the disease as most patients are being diagnosed too late in an emergency setting.

Professor Matthew Cramp, president at BASL, says: “Many people with liver disease are unaware that they have it because there are usually have no symptoms in the early stages. Too often the first a patient knows about their liver disease is when they are admitted as an emergency to hospital with life threatening complications. Even with the doctors’ best efforts some patients are so ill that their life cannot be saved.”

“It’s vital that GPs and other healthcare professionals identify those at risk so that more patients are diagnosed at an early stage.”

The research used Office for National Statistics mortality data and Hospital Episode Statistics data supplied by NHS Digital. Other alarming facts highlighted by the research:

• 29.1% of the patients who died in hospital had no previous admission in the year
• 20.8% had only one previous admission in the year before they died
• 25.3% of those who die do not survive more than 3 days in hospital
• 43% of those who die do not survive more than a week in hospital.
• 2,230 liver patients die each year in hospital in a week or less from admission, that is 43 patients per week or 6 patients every day.
• The majority (60%) of those dying from liver disease in hospital are under the age of 64 and 20% are under the age of 50.
• At least two-thirds of the patients who died with no previous admission in the year before death died from alcohol related liver disease
• Patients admitted to hospitals with specialist liver services are more likely to be seen by a specialist in liver disease and be admitted to ITU

Professor Matthew Cramp, president at BASL, says: “Despite being young and very sick, many patients die from the disease without ever being seen or cared for by a specialist. Patients with life-threatening liver disease complications need to be recognised quickly when they arrive at hospital and should be seen by a specialist with knowledge of liver disease quickly and treated according to Guidelines.”

This study found that the chance of these patients being seen by a specialist (Gastroenterologist or hepatologist) and being admitted to ITU was higher if they were admitted to a hospital with specialist liver services.

Matthew Cramp adds: “Smaller hospitals should link with specialist hospitals to consult with experts or transfer patients if appropriate.”
Liver problems develop silently with no obvious symptoms in the early stages yet if caught early, the disease can be reversed through lifestyle changes. More than 90% of liver disease is due to three main risk factors: obesity, alcohol and viral hepatitis.

Pamela Healy, Chief Executive, British Liver Trust said, “This research highlights the liver disease epidemic we are facing in the UK. While the data presented is based on England only, this is likely to reflect the situation with liver disease in Scotland, Wales and Northern Ireland.”

To coincide with the BASL conference, The British Liver Trust’s Love Your Liver roadshow is at the University of Strathclyde today offering free liver health screening and scanning.

Pamela continues: “Helping people understand how to reduce their risk of liver damage is vital to address the increase in deaths from liver disease. Although the liver is remarkably resilient, if left too late damage is often irreversible. I would urge everyone who is unable to attend the roadshow to take our online screener on our website to see if they are at risk.”

ENDS

1. For additional information of please refer to the following:
• The 2nd Atlas of variation in risk factors and healthcare for liver disease in England published by PHE and NHS Rightcare in 2017: https://fingertips.phe.org.uk/profile/atlas-of-variation 
• There is an interactive version of the Atlas at http://tools.england.nhs.uk/images/LiverAtlas17/atlas.html 
2. The Love Your Liver Campaign focuses on three simple steps to Love Your Liver back to health:
i) Drink within recommended limits and have three consecutive days off alcohol every week
ii) Cut down on sugar, carbohydrates and fat, and take more exercise
iii) Know the risk factors for viral hepatitis and get tested or vaccinated if at risk
3. The roadshow comprises a mobile unit where people can take a free online screening test and find out if they are at risk. Free liver health scanning is also offered using a non-invasive device. Expert guidance on how to keep your liver healthy from healthcare profession.